Filter News
Area of Research
- Advanced Manufacturing (7)
- Biology and Environment (12)
- Clean Energy (33)
- Computational Engineering (1)
- Computer Science (1)
- Fusion and Fission (4)
- Fusion Energy (1)
- Isotope Development and Production (1)
- Isotopes (2)
- Materials (33)
- Materials for Computing (3)
- National Security (11)
- Neutron Science (17)
- Nuclear Science and Technology (7)
- Supercomputing (32)
News Type
News Topics
- (-) 3-D Printing/Advanced Manufacturing (45)
- (-) Advanced Reactors (11)
- (-) Artificial Intelligence (34)
- (-) Biomedical (17)
- (-) Element Discovery (1)
- (-) Frontier (15)
- (-) Physics (24)
- (-) Space Exploration (3)
- Big Data (7)
- Bioenergy (23)
- Biology (22)
- Biotechnology (8)
- Buildings (15)
- Chemical Sciences (32)
- Clean Water (2)
- Climate Change (22)
- Composites (11)
- Computer Science (61)
- Coronavirus (17)
- Critical Materials (11)
- Cybersecurity (17)
- Decarbonization (20)
- Education (3)
- Energy Storage (43)
- Environment (36)
- Exascale Computing (10)
- Fossil Energy (1)
- Fusion (17)
- Grid (16)
- High-Performance Computing (30)
- Isotopes (18)
- ITER (2)
- Machine Learning (13)
- Materials (59)
- Materials Science (53)
- Mercury (2)
- Microelectronics (1)
- Microscopy (16)
- Molten Salt (3)
- Nanotechnology (26)
- National Security (18)
- Net Zero (3)
- Neutron Science (51)
- Nuclear Energy (27)
- Partnerships (29)
- Polymers (12)
- Quantum Computing (10)
- Quantum Science (27)
- Renewable Energy (1)
- Security (12)
- Simulation (9)
- Statistics (1)
- Summit (21)
- Sustainable Energy (30)
- Transformational Challenge Reactor (4)
- Transportation (25)
Media Contacts
OAK RIDGE, Tenn., March 20, 2019—Direct observations of the structure and catalytic mechanism of a prototypical kinase enzyme—protein kinase A or PKA—will provide researchers and drug developers with significantly enhanced abilities to understand and treat fatal diseases and neurological disorders such as cancer, diabetes, and cystic fibrosis.
OAK RIDGE, Tenn., March 11, 2019—An international collaboration including scientists at the Department of Energy’s Oak Ridge National Laboratory solved a 50-year-old puzzle that explains why beta decays of atomic nuclei
OAK RIDGE, Tenn., March 4, 2019—A team of researchers from the Department of Energy’s Oak Ridge National Laboratory Health Data Sciences Institute have harnessed the power of artificial intelligence to better match cancer patients with clinical trials.
The Department of Energy’s Oak Ridge National Laboratory is collaborating with industry on six new projects focused on advancing commercial nuclear energy technologies that offer potential improvements to current nuclear reactors and move new reactor designs closer to deployment.
A team of scientists has for the first time measured the elusive weak interaction between protons and neutrons in the nucleus of an atom. They had chosen the simplest nucleus consisting of one neutron and one proton for the study.
Scientists at the Department of Energy’s Oak Ridge National Laboratory have created a recipe for a renewable 3D printing feedstock that could spur a profitable new use for an intractable biorefinery byproduct: lignin.
Two leaders in US manufacturing innovation, Thomas Kurfess and Scott Smith, are joining the Department of Energy’s Oak Ridge National Laboratory to support its pioneering research in advanced manufacturing.
Three researchers from the Department of Energy’s Oak Ridge National Laboratory have been elected fellows of the American Physical Society (APS). Fellows of the APS are recognized for their exceptional contributions to the physics enterprise in outstanding resear...
The next cohort of Innovation Crossroads fellows at Oak Ridge National Laboratory will receive support from the U.S. Department of Energy’s Advanced Manufacturing Office (AMO) and the Tennessee Valley Authority (TVA). Officials made the announcement today at th...
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.